's new book maps the intersection of biotechnology and the business world in the last decades of the twentieth century. Gene Jockeys: Life Science and the Rise of Biotech Enterprise
(Johns Hopkins University Press, 2014) takes readers into the fascinating world of entrepreneur-biologists as they developed five of the first products of genetic engineering. Based on a documentary archive that includes oral history interviews and corporate documents resulting from patent litigation, Rasmussen's book emphasizes the agency of the biologists in in driving the development of first-generation recombinant DNA drugs like insulin, human growth hormone, and interferon. After an introduction to the development of basic molecular biology in a Cold War context - and paying special attention to the ways that Kuhn's notion of "normal science" helped shape the discipline - the ensuing chapters each present a case study that illustrates an important aspect of the history of biotech's rise as manifest in laboratories, courtrooms, universities, freezers, markets, and the public arena. Gene Jockeys
closes with a chapter that considers the policy lessons that can be taken from this story.